297 related articles for article (PubMed ID: 28683602)
1. Postoperative Levonorgestrel-Releasing Intrauterine System Insertion After Gonadotropin-Releasing Hormone Agonist Treatment for Preventing Endometriotic Cyst Recurrence: A Prospective Observational Study.
Kim MK; Chon SJ; Lee JH; Yun BH; Cho S; Choi YS; Lee BS; Seo SK
Reprod Sci; 2018 Jan; 25(1):39-43. PubMed ID: 28683602
[TBL] [Abstract][Full Text] [Related]
2. Postoperative levonorgestrel-releasing intrauterine system versus oral contraceptives after gonadotropin-releasing hormone agonist treatment for preventing endometrioma recurrence.
Cho S; Jung JA; Lee Y; Kim HY; Seo SK; Choi YS; Lee JS; Lee BS
Acta Obstet Gynecol Scand; 2014 Jan; 93(1):38-44. PubMed ID: 24605384
[TBL] [Abstract][Full Text] [Related]
3. Postoperative maintenance levonorgestrel-releasing intrauterine system and endometrioma recurrence: a randomized controlled study.
Chen YJ; Hsu TF; Huang BS; Tsai HW; Chang YH; Wang PH
Am J Obstet Gynecol; 2017 Jun; 216(6):582.e1-582.e9. PubMed ID: 28209488
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of levonorgestrel releasing intrauterine system as a postoperative maintenance therapy of endometriosis: A meta-analysis.
Song SY; Park M; Lee GW; Lee KH; Chang HK; Kwak SM; Yoo HJ
Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():85-92. PubMed ID: 30336309
[TBL] [Abstract][Full Text] [Related]
5. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.
Abou-Setta AM; Al-Inany HG; Farquhar CM
Cochrane Database Syst Rev; 2006 Oct; (4):CD005072. PubMed ID: 17054236
[TBL] [Abstract][Full Text] [Related]
6. Preventive therapeutic options for postoperative recurrence of ovarian endometrioma: gonadotropin-releasing hormone agonist with or without levonorgestrel intrauterine system insertion.
Zhu SY; Wu YS; Gu ZY; Zhang J; Jia SZ; Shi JH; Dai Y; Leng JH; Li XY
Arch Gynecol Obstet; 2021 Feb; 303(2):533-539. PubMed ID: 33104866
[TBL] [Abstract][Full Text] [Related]
7. [Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis].
Deng S; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):664-8. PubMed ID: 17199919
[TBL] [Abstract][Full Text] [Related]
8. Postoperative maintenance levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyoma.
Lin CJ; Hsu TF; Chang YH; Huang BS; Jiang LY; Wang PH; Chen YJ
Taiwan J Obstet Gynecol; 2018 Feb; 57(1):47-51. PubMed ID: 29458902
[TBL] [Abstract][Full Text] [Related]
9. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis.
Petta CA; Ferriani RA; Abrao MS; Hassan D; Rosa E Silva JC; Podgaec S; Bahamondes L
Hum Reprod; 2005 Jul; 20(7):1993-8. PubMed ID: 15790607
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy of diegnogest and levonorgestrel-releasing intrauterine system after laparoscopic surgery for endometriosis.
Lee KH; Jung YW; Song SY; Kang BH; Yang JB; Ko YB; Lee M; Han HY; Yoo HJ
J Obstet Gynaecol Res; 2018 Sep; 44(9):1779-1786. PubMed ID: 29974633
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of levonorgestrel-releasing intrauterine system in treatment of recurrent endometriosis after conservative surgery].
Xu XW; Zhang YW; He FF; Wang LD; Guan YT; Sun J; Lin M; Hu Y
Zhonghua Fu Chan Ke Za Zhi; 2011 Apr; 46(4):250-4. PubMed ID: 21609576
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis.
Lan S; Ling L; Jianhong Z; Xijing J; Lihui W
J Int Med Res; 2013 Jun; 41(3):548-58. PubMed ID: 23660087
[TBL] [Abstract][Full Text] [Related]
13. [Levonorgestrel-releasing intrauterine system and combined oral contraceptives as conservative treatments for recurrent ovarian endometriosis: a comparative clinical study].
Xu XW; Wang LD; Zhu XQ; Yan LZ; Guan YT; Zhu SC; Hu Y
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(15):1047-50. PubMed ID: 21609640
[TBL] [Abstract][Full Text] [Related]
14. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
Sheng J; Zhang WY; Zhang JP; Lu D
Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
[TBL] [Abstract][Full Text] [Related]
15. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.
Abou-Setta AM; Houston B; Al-Inany HG; Farquhar C
Cochrane Database Syst Rev; 2013 Jan; (1):CD005072. PubMed ID: 23440798
[TBL] [Abstract][Full Text] [Related]
16. Use of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrhea.
Bahamondes L; Petta CA; Fernandes A; Monteiro I
Contraception; 2007 Jun; 75(6 Suppl):S134-9. PubMed ID: 17531605
[TBL] [Abstract][Full Text] [Related]
17. The role of levonorgestrel-releasing intrauterine system for recurrence prevention after conservative surgery among patients with coexistent ovarian endometrioma and diffuse adenomyosis: A retrospective case control study with long-term follow up.
Shi JH; Zhu SY; Li XY; Dai Y; Leng JH
J Gynecol Obstet Hum Reprod; 2023 May; 52(5):102572. PubMed ID: 36914113
[TBL] [Abstract][Full Text] [Related]
18. The levonorgestrel-releasing intrauterine system is associated with a reduction in dysmenorrhoea and dyspareunia, a decrease in CA 125 levels, and an increase in quality of life in women with suspected endometriosis.
Yucel N; Baskent E; Karamustafaoglu Balci B; Goynumer G
Aust N Z J Obstet Gynaecol; 2018 Oct; 58(5):560-563. PubMed ID: 29359457
[TBL] [Abstract][Full Text] [Related]
19. Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system.
Li L; Leng J; Jia S; Lang J
Int J Gynaecol Obstet; 2019 Sep; 146(3):357-363. PubMed ID: 31194884
[TBL] [Abstract][Full Text] [Related]
20. Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue.
Bayoglu Tekin Y; Dilbaz B; Altinbas SK; Dilbaz S
Fertil Steril; 2011 Feb; 95(2):492-6. PubMed ID: 20883991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
